{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihqisqyzfl3ifv2o7anjk7i4tam3rgwo5rh4vowrkf72re4cplfpa",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjqg4ihrodx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiaiakj5b5funmw2d4m2u22dp3t2vwgc3wusi26n4375yn3qfvqyeu"
    },
    "mimeType": "image/jpeg",
    "size": 212374
  },
  "path": "/2026/04/17/revolution-medicines-daraxonrasib-clinical-trial-readout-loud-podcast-transcript/?utm_campaign=rss",
  "publishedAt": "2026-04-17T17:37:53.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "The Readout LOUD",
    "biotech",
    "Cancer",
    "pharmaceutical industry"
  ],
  "textContent": "\"I do think it's a revolution,\" said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.",
  "title": "STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment",
  "updatedAt": "2026-04-17T17:37:59.000Z"
}